{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T12:31:19Z","timestamp":1779366679322,"version":"3.53.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T00:00:00Z","timestamp":1538006400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006762","name":"Fullerton College Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12944-018-0870-x","type":"journal-article","created":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T17:36:30Z","timestamp":1538069790000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Stroke and dyslipidemia: clinical risk factors in the telestroke versus non-telestroke"],"prefix":"10.1186","volume":"17","author":[{"given":"Jordan","family":"Gainey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brice","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bekah","family":"Bowie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Cooley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Madeline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ervin Lowther","family":"Ervin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas I.","family":"Nathaniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,27]]},"reference":[{"key":"870_CR1","doi-asserted-by":"crossref","unstructured":"Pol T, Held C, Westerbergh J, Lindb\u00e4ck J, Alexander JH, Alings M, Erol C, Goto S, Halvorsen S, Huber K, Hanna M, Lopes RD, Ruzyllo W, Granger CB, Hijazi Z. Dyslipidemia and risk of cardiovascular events in patients with atrial fibrillation treated with Oral anticoagulation therapy: insights from the ARISTOTLE (Apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation) trial. J Am Heart Assoc. 2018;7.3:1\u201311.","DOI":"10.1161\/JAHA.117.007444"},{"issue":"3","key":"870_CR2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1001\/jama.2014.7692","volume":"312","author":"S Koton","year":"2014","unstructured":"Koton S, Schneider ALC, Rosamond WD, Shahar E, Sang YY, Gottesman RF, et al. Stroke incidence and mortality trends in US communities, 1987 to 2011. JAMA. 2014;312(3):259\u201368.","journal-title":"JAMA"},{"key":"870_CR3","first-page":"34","volume":"12","author":"M Jain","year":"2013","unstructured":"Jain M, Jain A, Yerragondu N, Brown RD, Rabinstein A, Jahromi B. The triglyceride paradox in stroke survivors: a prospective study. Neurosci J. 2013;12:34\u201341.","journal-title":"Neurosci J"},{"key":"870_CR4","doi-asserted-by":"crossref","unstructured":"Lu D, Li P, Zhou YY, Xu XI XL, Liu LP, Tian Z. Association between serum non-high-density lipoprotein cholesterol and cognitive impairment in patients with acute ischemic stroke. BMC Neurol. 2016;16:154.","DOI":"10.1186\/s12883-016-0668-2"},{"issue":"11","key":"870_CR5","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/sj.ejcn.1602643","volume":"61","author":"T Dziedzic","year":"2007","unstructured":"Dziedzic T, Pera J, Slowik A, Gryz-Kurek EA, Szczudlik A. Hypoalbuminemia in acute ischemic stroke patients: frequency and correlates. Eur J Clin Nutr. 2007;61(11):1318\u201322.","journal-title":"Eur J Clin Nutr"},{"issue":"1","key":"870_CR6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000070119","volume":"16","author":"CJ Weir","year":"2003","unstructured":"Weir CJ, Sattar N, Walters MR, Lees KR. Low triglyceride, not low cholesterol concentration, independently predicts poor outcome following acute stroke. Cerebrovasc Dis. 2003;16(1):76\u201382.","journal-title":"Cerebrovasc Dis"},{"issue":"8","key":"870_CR7","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1515\/CCLM.2008.233","volume":"46","author":"AM Simundic","year":"2008","unstructured":"Simundic AM, Nikolac N, Topic E, Basic-Kes V, Demarin V. Are serum lipids measured on stroke admission prognostic? Clin Chem Lab Med. 2008;46(8):1163\u20137.","journal-title":"Clin Chem Lab Med"},{"key":"870_CR8","first-page":"619","volume":"35","author":"A Tuttolomondo","year":"2013","unstructured":"Tuttolomondo A, Di Raimondo D, Pedone C, Pinto A, Licata G. Effects of clinical and laboratory variables at admission and of in-hospital treatment with cardiovascular drugs on short term prognosis of ischemic stroke. The GIFA study. Cerebrovasc Dis. 2013;35:619.","journal-title":"Cerebrovasc Dis"},{"issue":"3","key":"870_CR9","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1161\/CIRCRESAHA.116.308398","volume":"120","author":"AK Boehme","year":"2017","unstructured":"Boehme AK, Esenwa C, Elkind MSV. Stroke risk factors, genetics, and prevention. Circ Res. 2017;120(3):472\u201395.","journal-title":"Circ Res"},{"issue":"6","key":"870_CR10","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1161\/STROKEAHA.114.003825","volume":"45","author":"CF Bladin","year":"2014","unstructured":"Bladin CF, Cadilhac DA. Effect of Telestroke on emergent stroke care and stroke outcomes. Stroke. 2014;45(6):1876.","journal-title":"Stroke"},{"issue":"13","key":"870_CR11","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1212\/WNL.0b013e318212a8d4","volume":"76","author":"T Sairanen","year":"2011","unstructured":"Sairanen T, Soinila S, Nikkanen M, Rantanen K, Mustanoja S, Farkkila M, et al. Two years of Finnish Telestroke thrombolysis at spokes equal to that at the hub. Neurology. 2011;76(13):1145\u201352.","journal-title":"Neurology"},{"issue":"10","key":"870_CR12","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1080\/02699052.2016.1186840","volume":"30","author":"TI Nathaniel","year":"2016","unstructured":"Nathaniel TI, Cochran T, Chaves J, Fulmer E, Sosa C, Yi S, et al. Co-morbid conditions in use of recombinant tissue plasminogen activator (rt-PA) for the treatment of acute ischaemic stroke. Brain Inj. 2016;30(10):1261\u20135.","journal-title":"Brain Inj"},{"issue":"1","key":"870_CR13","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.advms.2017.08.003","volume":"63","author":"MJ Colello","year":"2018","unstructured":"Colello MJ, Ivey LE, Gainey J, Faulkner RV, Johnson A, Brechtel L, et al. Pharmacological thrombolysis for acute ischemic stroke treatment: gender differences in clinical risk factors. Adv Med Sci. 2018;63(1):100\u20136.","journal-title":"Adv Med Sci"},{"key":"870_CR14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jns.2018.02.016","volume":"387","author":"J Gainey","year":"2018","unstructured":"Gainey J, Brechtel L, Konklin S, Madeline L, Lowther E, Blum B, et al. In a stroke cohort with incident hypertension; are more women than men likely to be excluded from recombinant tissue-type plasminogen activator (rtPA)? J Neurol Sci. 2018;387:139\u201346.","journal-title":"J Neurol Sci"},{"issue":"1","key":"870_CR15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1161\/CIRCULATIONAHA.108.783688","volume":"119","author":"LH Schwamm","year":"2009","unstructured":"Schwamm LH, Fonarow GC, Reeves MJ, Pan W, Frankel MR, Smith EE, et al. Get with the guidelines-stroke is associated with sustained improvement in Care for Patients Hospitalized with Acute Stroke or transient ischemic attack. Circulation. 2009;119(1):107\u2013U206.","journal-title":"Circulation"},{"issue":"4","key":"870_CR16","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1067\/mpd.2003.205","volume":"142","author":"REW Kavey","year":"2003","unstructured":"Kavey REW, Daniels SR, Lauer RM, Atkins DL, Hayman LL, Taubert K. American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. J Pediatr. 2003;142(4):368\u201372.","journal-title":"J Pediatr"},{"issue":"8","key":"870_CR17","first-page":"1","volume":"11","author":"M Yao","year":"2016","unstructured":"Yao M, Ni J, Zhou L, Peng B, Zhu Y, Cui L. Elevated fasting blood glucose is predictive of poor outcome in non-diabetic stroke patients: a sub-group analysis of SMART. PLoS ONE. 2016;11(8):1\u201310.","journal-title":"PLoS ONE"},{"key":"870_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/dme.13067","volume":"34","author":"P Boovalingam","year":"2017","unstructured":"Boovalingam P, Chunduri A, Berberic S, Brawn L, Blake M, O'Kane D, et al. Assessment of severity and clinical outcome of acute Ischemic stroke in patients with diabetes compared with patients with chronic heart failure: retrospective case series. Diabet Med. 2017;34:93.","journal-title":"Diabet Med"},{"issue":"3","key":"870_CR19","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00415-008-0677-1","volume":"255","author":"A Ois","year":"2008","unstructured":"Ois A, Gomis M, Cuadrado-Godia E, Jimenez-Conde J, Rodriguez-Campello A, Bruguera J, et al. Heart failure in acute ischemic stroke. J Neurol. 2008;255(3):385\u20139.","journal-title":"J Neurol"},{"issue":"7416","key":"870_CR20","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1136\/bmj.327.7416.638-a","volume":"327","author":"JH Tanne","year":"2003","unstructured":"Tanne JH. Study shows what INR level is best for preventing stroke in patients with atrial fibrillation. Br Med J. 2003;327(7416):638.","journal-title":"Br Med J"},{"issue":"2","key":"870_CR21","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1161\/STROKEAHA.109.569707","volume":"41","author":"EL Thacker","year":"2010","unstructured":"Thacker EL, Wiggins KL, Rice KM, Longstreth WT, Bis JC, Dublin S, et al. Short-term and long-term risk of incident ischemic stroke after transient ischemic attack. Stroke. 2010;41(2):239\u201343.","journal-title":"Stroke"},{"issue":"4","key":"870_CR22","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.amjms.2016.01.011","volume":"351","author":"R Chen","year":"2016","unstructured":"Chen R, Ovbiagele B, Feng WW. Diabetes and stroke: epidemiology, pathophysiology, pharmaceuticals and outcomes. Am J Med Sci. 2016;351(4):380\u20136.","journal-title":"Am J Med Sci"},{"issue":"38","key":"870_CR23","doi-asserted-by":"publisher","first-page":"6195","DOI":"10.2174\/138161212803832236","volume":"18","author":"AE Duncan","year":"2012","unstructured":"Duncan AE. Hyperglycemia and perioperative glucose management. Curr Pharm Des. 2012;18(38):6195\u2013203.","journal-title":"Curr Pharm Des"},{"issue":"10","key":"870_CR24","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1161\/STROKEAHA.111.628479","volume":"42","author":"KG Haeusler","year":"2011","unstructured":"Haeusler KG, Laufs U, Endres M. Chronic heart failure and ischemic stroke. Stroke. 2011;42(10):2977\u2013U483.","journal-title":"Stroke"},{"issue":"6","key":"870_CR25","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.cardfail.2007.01.009","volume":"13","author":"BJ Witt","year":"2007","unstructured":"Witt BJ, Gami AS, Ballman KV, Brown RD, Meverden RA, Jacobsen SJ, et al. The incidence of ischemic stroke in chronic heart failure: a meta-analysis. J Card Fail. 2007;13(6):489\u201396.","journal-title":"J Card Fail"},{"issue":"1","key":"870_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ehf2.12026","volume":"2","author":"N Scherbakov","year":"2015","unstructured":"Scherbakov N, Haeusler KG, Doehner W. Ischemic stroke and heart failure: facts and numbers. Esc Heart Fail. 2015;2(1):1\u20134.","journal-title":"Esc Heart Fail"},{"issue":"4","key":"870_CR27","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.ncl.2008.09.001","volume":"26","author":"T Rundek","year":"2008","unstructured":"Rundek T, Sacco RL. Risk factor management to prevent first stroke. Neurol Clin. 2008;26(4):1007\u201345.","journal-title":"Neurol Clin"},{"issue":"11","key":"870_CR28","doi-asserted-by":"publisher","first-page":"E262-E","DOI":"10.1161\/STR.0000000000000110","volume":"47","author":"Demaerschalk","year":"2016","unstructured":"Demaerschalk. Scientific rationale for the inclusion and exclusion criteria for intravenous Alteplase in acute ischemic stroke: a statement for healthcare professionals from the American Heart Association\/American Stroke Association (vol 47, pg 581, 2016). Stroke. 2016;47(11):E262-E.","journal-title":"Stroke"},{"issue":"9","key":"870_CR29","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1212\/WNL.57.9.1739","volume":"57","author":"AM Buchan","year":"2001","unstructured":"Buchan AM. Why are stroke patients excluded from tPA therapy? An analysis of patient eligibility - reply. Neurology. 2001;57(9):1739\u201340.","journal-title":"Neurology"},{"issue":"2","key":"870_CR30","doi-asserted-by":"publisher","first-page":"309","DOI":"10.14336\/AD.2017.0406","volume":"9","author":"WU Chuanjie","year":"2018","unstructured":"Chuanjie WU, Di WU JC, Chuanhui L, Xunming J. why not intravenous thrombolysis in patients with recurrent stroke within 3 months? Ageing Dis. 2018;9(2):309\u201316.","journal-title":"Ageing Dis"},{"issue":"11","key":"870_CR31","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1161\/STROKEAHA.112.665331","volume":"43","author":"WN Whiteley","year":"2012","unstructured":"Whiteley WN, Slot KB, Fernandes P, Sandercock P, Wardlaw J. Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator a systematic review and meta-analysis of 55 studies. Stroke. 2012;43(11):2904\u2013U235.","journal-title":"Stroke"},{"key":"870_CR32","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1177\/1941875211408731","volume":"13","author":"DJ Miller","year":"2011","unstructured":"Miller DJ, Simpson JR. Silver B Safety of Thrombolysis in Acute Ischemic Stroke: A Review of Complications, Risk Factors, and Newer Technologies. Neurohospitalist. 2011;13:138\u201347.","journal-title":"Neurohospitalist"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-018-0870-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12944-018-0870-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-018-0870-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T19:04:49Z","timestamp":1569524689000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-018-0870-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,27]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["870"],"URL":"https:\/\/doi.org\/10.1186\/s12944-018-0870-x","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,27]]},"assertion":[{"value":"2 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study is a retrospective data analysis, and was approved by Institutional Review Board of Greenville Health System and the institutional Committee for Ethics.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All co-authors agreed to the submission of the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"226"}}